CYP19A1 and breast carcinoma: The CYP19 A1 Aromatase enzyme represents a critical enzyme for peripheral and intra-tumoral estrogen biosynthesis in post-menopausal breast cancer, and thereby provides growth-promoting estrogens via the conversion of E2 and E1 from testosterone and androstenedione, respectively [49,50].